Anphar is equipped with comprehensive R&D facility which continuously thrives for the development of new molecules, improvement in product quality and cost reduction of existing molecules.

Anphar's R&D strategy is to pursue significant areas of unmet medical need by leveraging our legacy in manufacturing high-potency molecules as well as our growing experience and expertise in highly targeted therapeutics.